Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia

Ok Kyu Park, Ki Yeon Yoo, Choong Hyun Lee, Jung Hoon Choi, In Koo Hwang, Jun Hong Park, Young-Guen Kwon, Young Myeong Kim, Moo Ho Won

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Melatonin is synthesized from serotonin by the action of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of arylalkylamine N-acetyltransferase (EC 2.3.1.87; AANAT) in the hippocampal CA1 region at various time points after ischemia/reperfusion. In vehicle-treated sham group, AANAT immunoreaction was detected in pyramidal neurons of the CA1 region. AANAT immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after ischemia/reperfusion. From 3 days after ischemia/reperfusion, AANAT immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after ischemia/reperfusion, and markedly decreased from 5 days after ischemia/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before ischemia/reperfusion significantly reduced ischemia-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated ischemia group. Melatonin treatment also maintained AANAT immunoreactivity and its protein levels in the CA1 region after ischemia/reperfusion. These results suggest that the reduction of AANAT in ischemic CA1 region is associated with delayed neuronal death following transient ischemia, and melatonin treatment shows neuroprotection with maintenance of AANAT levels in the ischemic CA1 region.

Original languageEnglish
Pages (from-to)7-17
Number of pages11
JournalJournal of the Neurological Sciences
Volume294
Issue number1-2
DOIs
Publication statusPublished - 2010 Jul 15

Fingerprint

Arylalkylamine N-Acetyltransferase
Gerbillinae
Transient Ischemic Attack
Melatonin
Astrocytes
Hippocampus
Ischemia
Reperfusion
Hippocampal CA1 Region
Acetylserotonin O-Methyltransferase
Pyramidal Cells
Serotonin
Proteins

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Park, Ok Kyu ; Yoo, Ki Yeon ; Lee, Choong Hyun ; Choi, Jung Hoon ; Hwang, In Koo ; Park, Jun Hong ; Kwon, Young-Guen ; Kim, Young Myeong ; Won, Moo Ho. / Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia. In: Journal of the Neurological Sciences. 2010 ; Vol. 294, No. 1-2. pp. 7-17.
@article{5dee6b0aced14cb5903f4b13b1e1d576,
title = "Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia",
abstract = "Melatonin is synthesized from serotonin by the action of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of arylalkylamine N-acetyltransferase (EC 2.3.1.87; AANAT) in the hippocampal CA1 region at various time points after ischemia/reperfusion. In vehicle-treated sham group, AANAT immunoreaction was detected in pyramidal neurons of the CA1 region. AANAT immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after ischemia/reperfusion. From 3 days after ischemia/reperfusion, AANAT immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after ischemia/reperfusion, and markedly decreased from 5 days after ischemia/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before ischemia/reperfusion significantly reduced ischemia-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated ischemia group. Melatonin treatment also maintained AANAT immunoreactivity and its protein levels in the CA1 region after ischemia/reperfusion. These results suggest that the reduction of AANAT in ischemic CA1 region is associated with delayed neuronal death following transient ischemia, and melatonin treatment shows neuroprotection with maintenance of AANAT levels in the ischemic CA1 region.",
author = "Park, {Ok Kyu} and Yoo, {Ki Yeon} and Lee, {Choong Hyun} and Choi, {Jung Hoon} and Hwang, {In Koo} and Park, {Jun Hong} and Young-Guen Kwon and Kim, {Young Myeong} and Won, {Moo Ho}",
year = "2010",
month = "7",
day = "15",
doi = "10.1016/j.jns.2010.04.013",
language = "English",
volume = "294",
pages = "7--17",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia. / Park, Ok Kyu; Yoo, Ki Yeon; Lee, Choong Hyun; Choi, Jung Hoon; Hwang, In Koo; Park, Jun Hong; Kwon, Young-Guen; Kim, Young Myeong; Won, Moo Ho.

In: Journal of the Neurological Sciences, Vol. 294, No. 1-2, 15.07.2010, p. 7-17.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia

AU - Park, Ok Kyu

AU - Yoo, Ki Yeon

AU - Lee, Choong Hyun

AU - Choi, Jung Hoon

AU - Hwang, In Koo

AU - Park, Jun Hong

AU - Kwon, Young-Guen

AU - Kim, Young Myeong

AU - Won, Moo Ho

PY - 2010/7/15

Y1 - 2010/7/15

N2 - Melatonin is synthesized from serotonin by the action of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of arylalkylamine N-acetyltransferase (EC 2.3.1.87; AANAT) in the hippocampal CA1 region at various time points after ischemia/reperfusion. In vehicle-treated sham group, AANAT immunoreaction was detected in pyramidal neurons of the CA1 region. AANAT immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after ischemia/reperfusion. From 3 days after ischemia/reperfusion, AANAT immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after ischemia/reperfusion, and markedly decreased from 5 days after ischemia/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before ischemia/reperfusion significantly reduced ischemia-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated ischemia group. Melatonin treatment also maintained AANAT immunoreactivity and its protein levels in the CA1 region after ischemia/reperfusion. These results suggest that the reduction of AANAT in ischemic CA1 region is associated with delayed neuronal death following transient ischemia, and melatonin treatment shows neuroprotection with maintenance of AANAT levels in the ischemic CA1 region.

AB - Melatonin is synthesized from serotonin by the action of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of arylalkylamine N-acetyltransferase (EC 2.3.1.87; AANAT) in the hippocampal CA1 region at various time points after ischemia/reperfusion. In vehicle-treated sham group, AANAT immunoreaction was detected in pyramidal neurons of the CA1 region. AANAT immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after ischemia/reperfusion. From 3 days after ischemia/reperfusion, AANAT immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after ischemia/reperfusion, and markedly decreased from 5 days after ischemia/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before ischemia/reperfusion significantly reduced ischemia-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated ischemia group. Melatonin treatment also maintained AANAT immunoreactivity and its protein levels in the CA1 region after ischemia/reperfusion. These results suggest that the reduction of AANAT in ischemic CA1 region is associated with delayed neuronal death following transient ischemia, and melatonin treatment shows neuroprotection with maintenance of AANAT levels in the ischemic CA1 region.

UR - http://www.scopus.com/inward/record.url?scp=77953288804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953288804&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2010.04.013

DO - 10.1016/j.jns.2010.04.013

M3 - Article

C2 - 20488463

AN - SCOPUS:77953288804

VL - 294

SP - 7

EP - 17

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -